Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Human Gene Therapy
|
February 20, 2020
ITRs: The Terminal Frontier
Phillip W L Tai
Human Gene Therapy
|
November 6, 2023
Integration of Gene Therapy Vectors: A Risk Factor for Tumorigenesis or Another Commensal Property of Adeno-Associated Viruses That Benefits Long-Term Transgene Expression?
Phillip W L Tai
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 25, 2024
AAV-RNAi constructs promote DRG toxicity
Jun Xie, Phillip W L Tai
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 18, 2023
Learning to lock down genetic diseases without throwing away the key
Phillip W L Tai, Jun Xie
Nature Reviews. Drug Discovery
|
February 3, 2019
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang, Phillip W L Tai, Guangping Gao
Frontiers in Immunology
|
May 28, 2021
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
Wei Zhan, Manish Muhuri, Phillip W L Tai, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 2, 2011
Analysis of muscle gene transcription in cultured skeletal muscle cells
Charis L Himeda, Phillip W L Tai, Stephen D Hauschka
Human Gene Therapy Methods
|
May 11, 2017
A Scalable and Accurate Method for Quantifying Vector Genomes of Recombinant Adeno-Associated Viruses in Crude Lysate
Jianzhong Ai, Raed Ibraheim, Phillip W L Tai, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 21, 2019
Intravenous Infusion of AAV for Widespread Gene Delivery to the Nervous System
Dominic J Gessler, Phillip W L Tai, Jia Li, et al.
Signal Transduction and Targeted Therapy
|
February 9, 2021
Viral vector platforms within the gene therapy landscape
Jote T Bulcha, Yi Wang, Hong Ma, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Human Gene Therapy
|
February 20, 2020
ITRs: The Terminal Frontier
Phillip W L Tai
Human Gene Therapy
|
November 6, 2023
Integration of Gene Therapy Vectors: A Risk Factor for Tumorigenesis or Another Commensal Property of Adeno-Associated Viruses That Benefits Long-Term Transgene Expression?
Phillip W L Tai
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 25, 2024
AAV-RNAi constructs promote DRG toxicity
Jun Xie, Phillip W L Tai
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 18, 2023
Learning to lock down genetic diseases without throwing away the key
Phillip W L Tai, Jun Xie
Nature Reviews. Drug Discovery
|
February 3, 2019
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang, Phillip W L Tai, Guangping Gao
Frontiers in Immunology
|
May 28, 2021
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
Wei Zhan, Manish Muhuri, Phillip W L Tai, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 2, 2011
Analysis of muscle gene transcription in cultured skeletal muscle cells
Charis L Himeda, Phillip W L Tai, Stephen D Hauschka
Human Gene Therapy Methods
|
May 11, 2017
A Scalable and Accurate Method for Quantifying Vector Genomes of Recombinant Adeno-Associated Viruses in Crude Lysate
Jianzhong Ai, Raed Ibraheim, Phillip W L Tai, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 21, 2019
Intravenous Infusion of AAV for Widespread Gene Delivery to the Nervous System
Dominic J Gessler, Phillip W L Tai, Jia Li, et al.
Signal Transduction and Targeted Therapy
|
February 9, 2021
Viral vector platforms within the gene therapy landscape
Jote T Bulcha, Yi Wang, Hong Ma, et al.
Page
of 6